HomeQuestion

How are you integrating the findings from KEYNOTE-689 into daily practice?

3

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

What would your approach be for a locally advanced head and neck cancer diagnosed concurrently with a mid-esophageal cancer?

For a patient s/p TORS with indications for adjuvant radiation, how does your management change with persistently elevated ctHPVDNA?

What is the role for chemo immunotherapy in the up front setting in non-metastatic head & neck cancer outside of clinical trials?

How would you approach a patient with synchronous HPV-mediated bilateral tonsil primary with ipsilateral lymph nodes who cannot receive chemotherapy?

For unresectable-appearing BRAF V600E papillary thyroid cancer involving the trachea and carotid artery, is neoadjuvant targeted therapy a viable path to surgery, or is definitive radiation the better option?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.

How are you integrating the findings from KEYNOTE-689 into daily practice? | Mednet